Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-73

Would not be so sure about that as the clock is ticking. "Assuming" they stay in the money, there is a finite time to exercise the options - Sept 26 and May 27. The beauty of unlisted Options FOR THE COMPANY is that they must be exercised and Capital contributed first, before any Shareholder can trade. A reasonably common strategy is to sell the Ordinary shares issued and hold the "no cost" Options.

Every chance some of that was happening last week - circa 70m shares traded in three days which will have cleared out a bunch of traders who have made good profits, no problem. What do they have left is the question?

Personally, stay with the Science - if a reduction of Cortisol improves Cognition safely, that is pretty big. As one shareholder said to me "old age might be 5000 steps + a Xanamem + an Asprin + a Statin every day...." Hold tight and await results